English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Molybdenum-99 is an important radionuclide which is used in nuclear medicine and a new method is presented for the isolation and purification of  99 Mo from fission material. The method was developed to suit the needs of the Nuclear Energy Corporation of South Africa (NECSA) and also because most other methods had been patented and could therefore not be used at NECSA. A uranium-aluminium alloy, cladded in aluminium, served as a target and the target was irradiated in a nuclear reactor for several days. After a cooling period, in order to let the short-lived radionuclides decay, the target material was dissolved in a sodium hydroxide solution. The radioactive krypton and xenon gases were collected on activated carbon and stored until both gases had decayed. Aluminium,  99 Mo,  131 I and the radionuclides of alkali-soluble elements in the sodium hydroxide solution were separated from the uranium and radionuclides of the alkaline-insoluble elements by filtration. The radionuclides of molybdenum and iodine were separated by anion exchange chromatography, in alkaline medium, from the bulk aluminium and radionuclides of other elements, such as barium, strontium and tellurium.  99 Mo was selectively eluted with a slightly alkaline lithium sulphate solution, leaving the iodine radionuclides on the resin. The  99 Mo eluant was acidified with oxalic acid and nitric acid and  99 Mo separated from the remaining aluminium and other radionuclides by anion exchange chromatography, in acid medium. After elution of  99 Mo, again with a slightly alkaline lithium sulphate solution, the eluant was acidified with nitric acid,  99 Mo concentrated on a chelating resin column and finally eluted with ammonia and evaporated to obtain  99 MoO 3  which was then dissolved in diluted sodium hydroxide solution. The purity of the final product was within the specifications of the British and European Pharmacopoiea and no further purification steps, such as sublimation, were required.

The isolation of 99 Mo from fission material for use in the 99 Mo/ 99m Tc generator for medical use